KLRS
Kalaris Therapeutics

91
Loading...
Loading...
News
all
press releases
News Placeholder
Kalaris Therapeutics Inc. (KLRS) Upgraded to Buy: Here's What You Should Know
Kalaris Therapeutics Inc. (KLRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·1mo ago

Latest KLRS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.